Model Agreement Research

Nationally approved standard location agreements help speed up the contracting process of industry-sponsored studies carried out in the NHS by creating the need for site-by-site verifications and local legal agreements. This enables an earlier start-up, improves the speed of industry-sponsored clinical trials and allows NHS patients to access innovative treatments faster. The series of model location agreements is supported by guidelines that set out the objectives and will detail how the agreement should be used in the development of clinical research contracts sponsored by pharmaceutical, biopharmaceutical or medical companies. As an educational and public institution, the university does not receive any royalties or benefits from its research. For this reason, and also because it is incompatible with the principle of best efforts, the university cannot accept contractual provisions guaranteeing results, sanction the failure of progress within fixed deadlines or provide for the retention of payments if the sponsor is not satisfied with the results. The university does not accept contracts with lump sum provisions preventing the UMCP researcher from conducting research for other related fields. This type of university-approved agreement is made available to researchers who can use it if they collaborate with an external organization on a sponsored research proposal. This agreement guarantees that the rights of both parties are respected during the submission of the offer and that the university is bound to this organization for possible subcontracting (except in certain circumstances). The team agreement requires internal routing and ORA approval.

Before routing, the academic researcher should fill in as much of the highlighted fill-in information as possible and follow the language instructions that are included when the university is the team leader or a subordinate member of the team. If you have any questions, please contact Cory Whitman, Contract Manager, at The standard agreement provided under the link below and the applicable Annex 2, approved by the university, are intended for researchers who can use it if they receive data from another organization. This agreement ensures that the data is properly protected against disclosure. The data usage agreement requires internal routing and ORA authorization. Before routing, the academic researcher should fill in as much fili-in information as possible and add the corresponding Annex 2, depending on the type of data received. Where appropriate, sponsors` publications can be checked to protect patent rights. In cases where the university has accepted a sponsor`s protected information as the necessary background data for a research project, the sponsor may verify the proposed publications in order to identify the accidental disclosure of such data. The procedures would normally allow at least thirty days to be initiated for such verifications.

This brief summary of the general principles applicable to research agreements between the University of Maryland (UM) and industrial and commercial organizations. The guide has been developed by the Office of Research Administration with the goal of facilitating our research relationship with your organization. The principles set out in this guide reflect the university`s position as a public educational institution that minimizes and reduces changes to future agreements. The University of Maryland has a history of collaborating with industry to support research that enters the university`s missions in teaching, research, and public service. Cooperative efforts are encouraged because they bring both mutual benefits and benefits to society. . . .

Leave a Comment

Filed under Uncategorized

Comments are closed.